Tuesday, 17 November 2026European Markets

VISTIN PHARMA Stock Went Up By Over 12% At Session Start On Friday

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of VISTIN PHARMA (Oslo Børs All-share Index_GI: VISTN.OL) jumped by a staggering 12.91% to kr18.80 at 10:41 EST on Friday, following the last session's upward trend. Oslo Børs All-share Index_GI is sliding 0.78% to kr1,405.92, after five consecutive sessions in a row of losses. This seems, as yet, a somewhat down trend trading session today.

About VISTIN PHARMA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin hydrochloride APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.96.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 19.58. Meaning, the purchaser of the share is investing kr19.58 for every norwegian krone of annual earnings.

Volume

Today's last reported volume for VISTIN PHARMA is 58691 which is 298.95% above its average volume of 14711.

Volatility

VISTIN PHARMA's last week, last month's, and last quarter's current intraday variation average was a negative 0.61%, a negative 0.13%, and a positive 2.18%.

VISTIN PHARMA's highest amplitude of average volatility was 2.76% (last week), 1.15% (last month), and 2.18% (last quarter).

More news about VISTIN PHARMA (VISTN.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 17 Feb 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›